| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.723 | 0.001 | 0.723 | Acetyl-CoA carboxylase inhibitor | 0.656 0.001 CID_154699663 | ||
| 0.701 | 0.001 | 0.701 | Acetyl-CoA carboxylase 2 inhibitor | 0.636 0.001 CID_154699663 | ||
| 0.598 | 0.021 | 0.598 | Antiobesity | 0.265 0.144 CID_154699663 | ||
| 0.557 | 0.036 | 0.557 | Cyclophilin D inhibitor | |||
| 0.435 | 0.005 | 0.435 | 5-Lipoxygenase inhibitor | 0.413 0.005 CID_154699663 | ||
| 0.388 | 0.002 | 0.388 | Acetyl-CoA carboxylase 1 inhibitor | 0.31 0.002 CID_154699663 | ||
| 0.399 | 0.037 | 0.409 | Lipoxygenase inhibitor | 0.409 0.035 CID_154699663 | CID_154699663 | |
| 0.368 | 0.054 | 0.368 | Immunomodulator | 0.292 0.087 CID_154699663 | ||
| 0.2 | 0.005 | 0.242 | Leukotriene synthesis inhibitor | 0.242 0.005 CID_154699663 | CID_154699663 | |
| 0.152 | 0.005 | 0.152 | Leukotriene A4 hydrolase inhibitor | |||
| 0.234 | 0.087 | 0.234 | Hypoglycemic | |||
| 0.176 | 0.03 | 0.2 | MAP3K9 inhibitor | 0.2 0.015 CID_154699663 | CID_154699663 | |
| 0.234 | 0.098 | 0.234 | 5 Hydroxytryptamine uptake stimulant | 0.209 0.135 CID_154699663 | ||
| 0.139 | 0.013 | 0.139 | Alpha 2d adrenoreceptor antagonist | |||
| 0.131 | 0.019 | 0.131 | Somatostatin 1 agonist | 0.096 0.037 CID_154699663 | ||
| 0.118 | 0.027 | 0.118 | I kappa B kinase inhibitor | |||
| 0.242 | 0.155 | 0.242 | Toll-Like receptor 7 agonist | |||
| 0.132 | 0.046 | 0.14 | Aminopeptidase B inhibitor | 0.14 0.042 CID_154699663 | CID_154699663 | |
| 0.097 | 0.014 | 0.097 | I kappa B kinase 2 inhibitor | |||
| 0.24 | 0.157 | 0.24 | Toll-Like receptor agonist | |||
| 0.083 | 0.042 | 0.098 | Glutamate dehydrogenase inhibitor | 0.098 0.032 CID_154699663 | CID_154699663 | |
| 0.061 | 0.021 | 0.061 | Complement C3a chemotactic receptor antagonist | 0.057 0.023 CID_154699663 | ||
| 0.217 | 0.18 | 0.344 | Immunosuppressant | 0.344 0.09 CID_154699663 | CID_154699663 | |
| 0.066 | 0.037 | 0.08 | Carbamoyl phosphate synthetase inhibitor | 0.08 0.029 CID_154699663 | CID_154699663 | |
| 0.048 | 0.023 | 0.048 | Histamine H2 receptor agonist | |||
| 0.098 | 0.075 | 0.098 | Factor V inhibitor | 0.095 0.081 CID_154699663 | ||
| 0.033 | 0.011 | 0.033 | Antidiuretic hormone agonist | |||
| 0.033 | 0.011 | 0.033 | Vasopressin 1A agonist | |||
| 0.062 | 0.043 | 0.062 | Trypsin inhibitor | |||
| 0.046 | 0.027 | 0.046 | Oxytocin agonist | |||
| 0.026 | 0.009 | 0.026 | Vasopressin 1 agonist | |||
| 0.031 | 0.014 | 0.031 | HCV NS5A inhibitor | |||
| 0.047 | 0.038 | 0.047 | Dopamine beta hydroxylase inhibitor | |||
| 0.058 | 0.05 | 0.058 | NMDA receptor agonist | |||
| 0.018 | 0.01 | 0.018 | Vasopressin 2 agonist | |||
| 0.048 | 0.041 | 0.056 | Ornithine carbamoyltransferase inhibitor | 0.056 0.034 CID_154699663 | CID_154699663 | |
| 0.087 | 0.08 | 0.087 | Electrolyte absorption antagonist | |||
| 0.142 | 0.139 | 0.205 | Platelet aggregation inhibitor | 0.205 0.078 CID_154699663 | CID_154699663 | |
| 0.063 | 0.065 | 0.072 | Glutamate decarboxylase inhibitor | 0.072 0.053 CID_154699663 | CID_154699663 | |
| 0.023 | 0.031 | 0.028 | Thrombin receptor antagonist | 0.028 0.02 CID_154699663 | CID_154699663 | |
| 0.129 | 0.144 | 0.14 | ATPase inhibitor | 0.14 0.119 CID_154699663 | CID_154699663 | |
| 0.109 | 0.126 | 0.141 | Acetylcholine M1 receptor antagonist | 0.141 0.083 CID_154699663 | CID_154699663 | |
| 0.084 | 0.103 | 0.096 | Adenylate kinase inhibitor | 0.096 0.074 CID_154699663 | CID_154699663 | |
| 0.177 | 0.203 | 0.284 | MAP kinase kinase 3 inhibitor | 0.284 0.011 CID_154699663 | CID_154699663 | |
| 0.051 | 0.103 | 0.066 | Beta 2 adrenoreceptor agonist | 0.066 0.028 CID_154699663 | CID_154699663 | |
| 0.082 | 0.135 | 0.111 | Alpha-N-acetylglucosaminidase inhibitor | 0.111 0.088 CID_154699663 | CID_154699663 | |
| 0.051 | 0.109 | 0.108 | Ornithine decarboxylase inhibitor | 0.108 0.036 CID_154699663 | CID_154699663 | |
| 0.039 | 0.112 | 0.061 | Beta adrenoreceptor antagonist | 0.061 0.054 CID_154699663 | CID_154699663 | |
| 0.01 | 0.103 | 0.29 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.29 0.003 CID_154699663 | CID_154699663 | |
| 0.031 | 0.132 | 0.044 | Beta adrenoreceptor agonist | 0.044 0.038 CID_154699663 | CID_154699663 | |
| 0.04 | 0.276 | 0.096 | MAP kinase kinase 1 inhibitor | 0.096 0.061 CID_154699663 | CID_154699663 | |
| 0.022 | 0.268 | 0.213 | Check point kinase 2 inhibitor | 0.213 0.014 CID_154699663 | CID_154699663 | |
| 0.128 | 0.459 | 0.403 | Antiinflammatory | 0.403 0.138 CID_154699663 | CID_154699663 | |
| 0.009 | 0.413 | 0.083 | Dopamine transporter inhibitor | 0.083 0.016 CID_154699663 | CID_154699663 | |
| 0.005 | 0.452 | 0.063 | 5 Hydroxytryptamine uptake inhibitor | 0.063 0.044 CID_154699663 | CID_154699663 | |
| 0.019 | 0.545 | 0.144 | Anticonvulsant | 0.144 0.137 CID_154699663 | CID_154699663 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |